Literature DB >> 2553002

Effects of vanadate on protein kinases in rat hepatocytes.

C Villar-Palasi1, J J Guinovart, A M Gómez-Foix, J E Rodriguez-Gil, F Bosch.   

Abstract

In rat hepatocytes, vanadate modifies neither the intracellular concentration of cyclic AMP nor the --cyclic AMP/+cyclic AMP activity ratio for cyclic AMP-dependent protein kinase. Vanadate can, however, counteract the increase in cyclic AMP and the increase in the --cyclic AMP/+cyclic AMP activity ratio of cyclic AMP-dependent protein kinase induced by glucagon. On the other hand, vanadate treatment of hepatocytes can produce a time- and concentration-dependent increase in cyclic AMP- and Ca2+-independent casein kinase activity. Maximal activation at the optimal time with 5 mM-vanadate was about 70% over control. A clear relationship was observed between the activation of casein kinase and the inactivation of glycogen synthase after vanadate treatment. These results suggest that casein kinase activity may be involved in vanadate actions in rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553002      PMCID: PMC1133305          DOI: 10.1042/bj2620563

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the phosphorylation state.

Authors:  J J Guinovart; A Salavert; J Massagué; C J Ciudad; E Salsas; E Itarte
Journal:  FEBS Lett       Date:  1979-10-15       Impact factor: 4.124

2.  Effect of vanadate on cardiac contraction and adenylate cyclase.

Authors:  G Grupp; I Grupp; C L Johnson; E T Wallick; A Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1979-05-28       Impact factor: 3.575

3.  Activation of adenylate cyclase by vanadate.

Authors:  U Schwabe; C Puchstein; H Hannemann; E Söchtig
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

4.  Studies on alpha-adrenergic activation of hepatic glucose output. Insulin inhibition of alpha-adrenergic and glucagon actions in normal and calcium-depleted hepatocytes.

Authors:  P F Blackmore; F Assimacopoulos-Jeannet; T M Chan; J H Exton
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

5.  Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon.

Authors:  E G Loten; F D Assimacopoulos-Jeannet; J H Exton; C R Park
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

6.  Purification and characterization of an inhibitor protein of cyclic AMP-dependent protein kinases.

Authors:  C D Ashby; D A Walsh
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  Effects of vanadate on the cyclic AMP-protein kinase system in rat liver.

Authors:  R E Catalán; A M Martínez; M D Aragonés
Journal:  Biochem Biophys Res Commun       Date:  1980-09-30       Impact factor: 3.575

8.  The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor.

Authors:  G R Dubyak; A Kleinzeller
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

9.  Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions.

Authors:  Y Shechter; S J Karlish
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

10.  A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes.

Authors:  S Tamura; T A Brown; J H Whipple; Y Fujita-Yamaguchi; R E Dubler; K Cheng; J Larner
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

View more
  2 in total

1.  Effect of vanadium compounds on acid phosphatase activity.

Authors:  C M Vescina; V C Sálice; A M Cortizo; S B Etcheverry
Journal:  Biol Trace Elem Res       Date:  1996       Impact factor: 3.738

2.  Vanadium oxoanions and cAMP-dependent protein kinase: an anti-substrate inhibitor.

Authors:  S Pluskey; M Mahroof-Tahir; D C Crans; D S Lawrence
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.